PPARGC1B and fatty liver disease: The results revealed that the proteins interacting with PGC-1β were enriched in pathways related to fatty liver disease (Figure 6A) and were involved in PPARA, thereby activating gene expression, the nuclear receptor transcription pathway, and the intracellular receptor signaling pathway (Figures 6B–D).